Regeneron Study Site

La Mesa, California

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Atopic Dermatitis Clinical Trial
Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)
Status: Enrolling, Phase I
Updated: 1/4/2016
Regeneron Study Site
mi
from
La Mesa, CA
Click here to add this to my saved trials